Abstract:Cathepsin K (Cat-K) highly expressed in osteoclasts, is considered to be a promising target for osteoclast-related maladies. In the present study, quantitative structure–activity relationships (QSAR) and molecular docking approaches were used to identify promising Cat-K inhibitors from a series of Amide-Ac6-aminoacetonitriles analogs. During the two-dimensional QSAR study, the statistical model PLS_MDL was chosen (r2 = 0.823, q2 (cross-validation) = 0.732). Descriptors with positive or negative contributions were derived from model PLS_MDL. In order to build robust three-dimensional QSAR models, three different molecular fingerprints were used as analysis precepts for clustering and three different minimization algorithms were employed for generation of molecular poses. The best database which used molecular fingerprint of FCFP and minimization algorithm of Smart Minimizer was selected for further QSAR model construction. The ideal CoMFA and CoMSIA models were acquired (CoMFA: r2 = 0.963, q2 = 0.674, r2pred = 0.702 and Q2 (F2) = 0.616; CoMSIA_SEHA: r2 = 0.989, q2 = 0.622, r2pred = 0.719 and Q2 (F2) = 0.638). Physicochemical, structural, electrostatic, and steric properties were derived from the created QSAR models and then applied to portray a design scheme. Furthermore, after a selecting of docking scheme, docking studies were carried out to measure the binding affinity of eligible query compounds and to reveal the detailed interactions between ligand and the target protein. Amongst these designed compounds, compound19OX32 was focused for its preferable predicted activity and docking score. Strong interactions and extra hydrogen bonds which echoed the previous summarized design scheme were also observed via a deep investigation of docking result. Consequently, compound 19OX32 was identified as promising Cat-K inhibitor.

Efficient Large-Scale Synthesis of Cat811, A Potent Calpain Inhibitor of Interest in the Treatment of Cataracts

An efficient and concise synthesis of a selective small molecule non-peptide inhibitor of cathepsin L: KGP94

Lead optimization of cathepsin K inhibitors for the treatment of Osteoarthritis

Design and Synthesis of Novel Cathepsin C Inhibitors with Anti-Inflammatory Activity

Highly Selective Aza-Nitrile Inhibitors for Cathepsin K, Structural Optimization and Molecular Modeling

Cinnamaldehyde hydrazone derivatives as potential cathepsin B inhibitors: parallel in-vitro investigation in liver and cerebrospinal fluid

An update on the therapeutic potential of calpain inhibitors: a patent review

Efficient Enzymatic Cyclization of Disulfide-Rich Peptides by Using Peptide Ligases

An approach combining deep learning and molecule docking for drug discovery of cathepsin L

New Tripeptide-Based Macrocyclic Calpain Inhibitors Formed by N-Alkylation of Histidine

Structure‐Based Design of Bicyclic Helical Peptides That Target the Oncogene β‐Catenin

Advances in Cathepsin S Inhibition: Challenges and Breakthroughs in Drug Development

Identification of novel potential cathepsin-B inhibitors through pharmacophore-based virtual screening, molecular docking, and dynamics simulation studies for the treatment of Alzheimer's disease

Cyanobacterial peptides as a prototype for the design of cathepsin D inhibitors.

Development Of A Concise, Scalable Synthesis Of A Ccr1 Antagonist Utilizing A Continuous Flow Curtius Rearrangement

Scalable synthesis and structural characterization of reversible KLK6 inhibitors

Exploring the Limits of Cyanobactin Macrocyclase PatGmac: Cyclization of PawS-Derived Peptide Sunflower Trypsin Inhibitor-1 and Cyclotide Kalata B1

Novel thiazolotriazole and triazolothiadiazine scaffolds as selective tumor associated carbonic anhydrase inhibitors endowed with cathepsin B inhibition

Scalable Total Syntheses of (±)-Catellatolactams A and B

Linearizable Macrocyclic Peptide Libraries for Affinity Selection-Mass Spectrometry

A Combined approach of QSAR study, molecular docking and pharmacokinetics prediction of promising Amide-Ac6-aminoacetonitriles Cathepsin K inhibitors